Safety Issues Associated with Herbal Ingredients

Advances in Food and Nutrition Research

Volumn 50, Issue , 2005, Pages 219-313

  Elvin Lewis, Memory ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLANT EXTRACT;

CHILD; DRUG CONTAMINATION; FEMALE; GOVERNMENT REGULATION; HERB DRUG INTERACTION; HERBAL MEDICINE; HUMAN; HYPERSENSITIVITY; INTERNATIONAL COOPERATION; LEGAL ASPECT; MEDICINAL PLANT; PHYTOTHERAPY; PREGNANCY; REVIEW; SAFETY; STANDARD; TRADITIONAL MEDICINE;

CHILD; CONSUMER PRODUCT SAFETY; DRUG CONTAMINATION; FEMALE; GOVERNMENT REGULATION; HERB-DRUG INTERACTIONS; HERBAL MEDICINE; HUMANS; HYPERSENSITIVITY; INTERNATIONALITY; MEDICINE, TRADITIONAL; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PREGNANCY;

EID: 33645929413     PISSN: 10434526     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1043-4526(05)50007-X     Document Type: Review

References (418)

1. Adachi M., Saito H., Kobayashi H., Horie Y., Kato S., Yoshioka M., and Ishii H. Hepatic injury in 12 patients taking the herbal weight loss AIDS Chaso or Onshido. Ann. Intern. Med. 139 (2003) 488-492
2. Alexander F., Patheal S., Biondi A., Brandalise S., Cabrera M., Chan L., Chen Z., Cimino G., Cordoba J., Gu L., Hussein H., Ishii E., Kamel A., Labra S., Magalhaes I., Mizutani S., Petridou E., de Oliveira M., Yuen P., Wiemels J., and Greaves M. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res. 61 (2001) 2542-2546
3. al Khayat A., Menon N., and Alidina M. Acute lead encephalopathy in early infancy-clinical presentation and outcome. Ann. Trop. Paediatr. 17 (1997) 3944
4. Allen C. Viadent-related leukoplakia-the tip of the iceberg?. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodont. 87 (1999) 393-394
5. Almeida J.C., and Grimsley E.W. Coma from the health food store: Interaction between kava and alprazolam. Ann. Intern. Med. 125 (1996) 940-941
6. Alvarez M., Jacobs S., Jiang S.B., Brancaccio R.R., Soter N.A., and Cohen D.E. Photocontact allergy to diallyl disulfide. Am. J. Contact Dermat. 14 (2003) 161-165
7. American Association of Health Plans. "Formularies" (1998), American Association of Health Plans, Washington, DC
8. American Herbal Products Association. "Does an Organic Label Matter for Herbal Products"? (2004), American Herbal Products Association, Silver Springs, MD
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. (2000), American Psychiatric Association, Washington, D.C. p. 943.
10. Anderson I., Mullen W., Meeker J., Khojasteh-Bakht S., Oishi S., Nelson S., and Blanc P. Pennyroyal toxicity: Measurement of toxic metabolite levels in two cases and review of the literature. Ann. Intern. Med. 124 (1996) 726-734
11. Ang H. An insight into Malaysian herbal medicines. Trends Pharmacol. Sci. 25 (2004) 297-298
12. Ang H., Lee K., and Kiyoshi M. Determination of lead in Smilax myosotiflora herbal preparations obtained in Malaysia. Int. J. Environ. Health Res. 14 (2004) 261-272
13. Angell M., and Kassirer J.P. Alternative medicine-the risks of untested and unregulated remedies. N. Engl. J. Med. 339 (1998) 839-841
14. Anonymous. ANH New Zealand under pressure: Alliance for Natural Health. http://www.newmediaexplorer.org/australiansupplementlawsfornewzealand.html.2003
15. Epidemiologic notes and reports cadmium and lead exposure associated with pharmaceutical imported from Asia-Texas. MMWR Morb. Mortal. Wkly. Rep. 38 (1989) 612-614
16. Anonymous. Ginseng Safety. Herbal Safety Neus, Dec. 20. Medicines Control Agency (2003). http://medicines.mhra.gov.uk
17. Anonymous. Maternal use of Ginseng and neonatal androgenization. JAMA 265 (1991) 1828
18. Anonymous. Chaparral-induced toxic hepatitis-California and Texas. MMWR Morb. Mortal. Wkly. Rep. 41 (1992) 812-814
19. Anonymous. "Pharmaceutical Administration in Japan",. 8th Ed. (1998), Ministry of Health and Welfare, Yakuji Nippo., Ltd 37
20. Anonymous. Regulations on herbal extracts industry likely. "The Hindu" (2004) [Online Edition]. Kochi, Kerala
21. Argento A.T.E., and Marzaloni M. Oral anticoagulants and medicinal plants. An emerging interaction. Review [in Italian]. Ann. Ital. Med. Intl. 15 (2000) 139-143
22. Asafu-Adjaye E.B., and Wong S.K. Determination of ginsenosides (ginseng saponins) in dry root powder from Panax ginseng, Panax quinquefolius, and selected commercial products by liquid chromatography: Interlaboratory study. J. Am. Organ. Analyt. Chemists Intl. 86 (2003) 1112-1123
23. Ashar B.H., Miller R.G., Getz K.J., and Pichard C.P. A critical evaluation of Internet marketing of products that contain ephedra. Mayo Clin. Proc. 78 (2003) 944-946
24. Aslam M., and Stockley I. Interaction between curry ingredient (karela) and drug (chlorpropamide). Lancet 1 (1979) 607
25. Attef O., Ali A.A., and Ali H.M. Effect of Khat chewing on the bioavailability of ampicillin and amoxicillin. J. Antimicrob. Chemother. 39 (1997) 523-525
26. Au A.M., Ko R., Boo F.O., Hsu R., Perez G., and Yang Z. Screening methods for drugs and heavy metals in Chinese patent medicines. Bull. Environ. Contam. Toxicol. 65 (2000) 112-119
27. Awang D. Siberian ginseng toxicity may be case of mistaken identity. CMAJ Can. Med. Assoc. J. 155 (1996) 1237
28. Bailey D., Malcolm J., Arnold O., and Spence J. Grapefruit juice-drug interactions. Br. J. Clin. Pharmacol. 46 (1998) 101-110
29. Bailey D., Spence J., Edgar B., Bayliff C., and Arnold J. Ethanol enhances the hemodynamic effects of felodipine. Clin. Investig. Med. 12 (1989) 357-362
30. Bajaj J., Knox J.F., Komorowski R., and Saeian K. The irony of herbal hepatitis: Ma-Huang-induced hepatotoxicity associated with compound heterozygosity for hereditary hemochromatosis. Digest. Dis. Sci. 48 (2003) 1925-1928
31. Baker S., and Thomas P. Herbal medicine precipitating massive haemolysis. Lancet 1 (1987) 1039-1040
32. Ball S., Kertesz D., and Moyer-Mileur L. Dietary supplement use is prevalent among children with a chronic illness. J. Am. Diet. Assoc. 105 (2005) 78-84
33. Barbenel D., Yusufi B., O'Shea D., and Bench C. Mania in a patient receiving testosterone replacement postorchidectomy taking St John's wort and sertraline. J. Psychopharmacol. 14 (2000) 84-86
34. Beaugerie L., Luboinski J., Brousse N., Cosnes J., Chatelet F., Gendre J., and Le Quintrec Y. Drug induced lymphocytic colitis. Gut 35 (1994) 426-428
35. Belcaro G., Cesarone M.R., Rohdewald P., Ricci A., Ippolito E., Dugall M., Griffin M., Ruffini I., Acerbi G., Vinciguerra M.G., Bavera P., Di Renzo A., Errichi B.M., and Cerritelli F. Prevention of venous thrombosis and thrombophlebitis in long-haul flights with Pycnogenol. Clin. Applied Thromb. Hemostas. 10 (2004) 373-377
36. Benner M., and Lee H. Anaphylactic reaction to chamomile tea. J. Allergy Clin. Immunol. 52 (1973) 307-308
37. Benninger J., Schneider H., Schuppan D., Kirchner T., and Hahn E. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology 117 (1999) 1234-1237
38. Bensky D., and Gamble A. "Chinese Herbal Medicine: Materia Medica". revised edition (1993), Eastland Press, Inc., Seattle
39. Bensoussan A., Myers S., and Carlton A. Risks associated with the practice of traditional Chinese medicine. Arch. Fam. Med. 9 (2000) 1071-1078
40. Bent S., Tiedt T.N., Odden M.C., and Shlipak M.G. The relative safety of ephedra compared with other herbal products. Ann. Intern. Med. 138 156 (2003) 468-471
41. Beuers U., Spengler U., and Pape G. Hepatitis after chronic abuse of senna. Lancet 337 (1991) 372-373
42. Block K., and Mead M. Immune system effects of Echinachea, Ginseng, and Astragalus: A review. Integr. Cancer Ther. 2 (2003) 247-267
43. Blumenthal M. Dear Reader. Herbalgram 64 (2005) 5
44. Blumenthal M., Busse W.R., Goldberg A., Gruenwald J., Hall T., Riggins C.W., and Rister R.S. "The Complete German Commission E Monographs" (1998), American Botanical Council, Austin, Texas
45. Blumenthal M., Goldberg A., and Brinckmann J. "Herbal Medicine: Expanded Commission E Monographs" (2000), Integrative Medicine Communications, Newton, MA
46. Bonakdar R. Herbal cancer cures on the Web: Noncompliance with the Dietary Supplement Health and Education Act. Fam. Med. 34 (2002) 522-527
47. Borins M. The dangers of using herbs. What your patients need to know. Postgrad. Med. 104 101 (1998) 191-105, 199-100
48. Borum M. Fulminant exacerbation of autoimmune hepatitis after the use of ma huang. Am. J. Gastroenterol. 96 (2001) 1654-1655
49. Bradley P. "British Herbal Compedium" (1992), British Herbal Medicine Association, Bornemouth, Hampshire, England
50. Brauer A., Pfab R., Becker K., Berger H., and Stangl M. Fulminantes leberversagen nach einahme des pflazlichen heilmittels kava-kava. Zeit. Gastroenterol. 39 (2001) 216-218
51. Brazier N., and Levine M. Drug-herb interaction among commonly used conventional medicines: A compendium for health care professionals. Am. J. Therapeut. 10 (2003) 163-169
52. Brent J. Three new herbal hepatotoxic syndromes. J. Toxicol. Clin. Toxicol. 37 (1998) 715-719
53. Brinker F. "Herb Contraindications and Drug Interactions" (2001), Eclectic Medical Publishers, Sandy, OR
54. Burkill H.M. "The Useful Plants of West Tropical Africa (A-D)",. 2 Ed. (1985), Royal Botanic Gardens, Kew . Whitefriars Press Ltd, Towbridge, Kent
55. Burkill H.M. "The Useful Plants of West Tropical Africa (E-I)",. 2 Ed. (1994), Royal Botanic Gardens, Kew . British Printing Company Ltd
56. Burkill H.M. "The Useful Plants of West Tropical Africa (J-L)",. 2 Ed. (1995), Royal Botanic Gardens, Kew . British Printing Company Ltd
57. Burkill H.M. "The Useful Plants of West Tropical Africa (M-R)",. 2 Ed. (1997), Royal Botanic Gardens, Kew . British Printing Company Ltd, Richmond Surrey
58. Burkill H.M. "The Useful Plants of West Tropical Africa (S-Z)",. 2 Ed. (2000), Royal Botanic Gardens, Kew . British Printing Company Ltd, Richmond, Surrey
59. Bury R., Fullinfaw R.O., Barraclough D., Muirden K., and Moulds R. Problems with herbal medicines. Med. J. Aust. 146 (1987) 324-325
60. But P. Herbal poisoning caused by adulterants or erroneous substitutes. J. Trop. Med. Hyg. 97 (1994) 371-374
61. But P., Tomlinson B., and Lee K.L. Hepatitis related to the Chinese medicine Shou-wu-pian manufactured from Polygonum multiflorum. Vet. Human Toxicol. 38 (1996) 280-282
62. Cahill D.I., Fox R., Wardle P.G., and Harlow C.R. Multiple follicular development associated with herbal medicine. Human Reproduction 9 (1994) 1469-1470
63. Chan K. Some aspects of toxic contaminants in herbal medicines. Chemosphere 52 (2003) 1361-1371
64. Chan L., Chiu P., and Lau T. An in-vitro study of ginsenoside Rb1-induced teratogenicity using a whole rat embryo culture model. Human Reprod. 18 (2003) 2166-2168
65. Chan T. The prevalence use and harmful potential of some Chinese herbal medicines in babies and children. Vet. Hum. Toxicol. 36 (1994) 238-240
66. Chan T. Anticholinergic poisoning due to Chinese herbal medicines. Vet. Hum. Toxicol. 37 (1995) 156-157
67. Chan T. Incidence of herb-induced aconitine poisoning in Hong Kong: Impact of publicity measures to promote awareness among the herbalists and the public. Drug Safety 25 (2002) 823-828
68. Chan T., Chan J., Tomlinson B., and Critchley J. Poisoning by Chinese herbal medicines in Hong Kong: A hospital-based study. Vet. Hum. Toxicol. 36 (1994) 546-547
69. Chan Y. Monitoring the safety of herbal medicines. Drug Safety 17 (1997) 209-215
70. Cheeseman H., and Neal M. Interaction of chlorpromazine with tea and coffee. British J. Clin. Pharmacol. 12 (1981) 165-169
71. Chen H.H., Tseng M.P., and Hsu C.J. A patch test study of 27 crude drugs commonly used in Chinese topical medicaments. Contact Dermat. 49 (2003) 8-14
72. Chen L., Chou M., Lin M., and Yang L. Effects of Paeoniae Radix, a traditional Chinese medicine, on the pharmacokinetics of phenytoin. J. Clin. Pharmacol. Ther. 26 (2001) 271-278
73. Chen M., Shimada F., Kato H., Yano S., and Kanaoka M. Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone. Endocrinol. Jpn. 38 (1991) 167-174
74. Chetty M., Miller R., and Moodley S. Smoking and body weight influence the clearance of chlorpromazine. Eur. J. Clin. Pharmacol. 46 (1994) 523-526
75. Chia B., Leng C., Hsii F.P., Yap M.H., and Lee Y.K. Lead poisoning from contaminated opium. Br. Med. J. 1 5849 (1973) 354
76. Chisholm J., Fish D., and Tingey D. Health professions council recommendation on the designation of traditional chinese medicine (1998). (updated 2004). Ministry of Health Services. B.C. Canada. http://www.hlth.gov.bc.ca/1g/hpc/reports/apps-tem.html/ISS
77. Chitturi S., and Farrell G.C. Herbal hepatotoxicity: An expanding but poorly defined problem. J. Gastroenterol. Hepatol. 15 (2000) 1093-1099
78. Chiu A., Lane A., and Kimball A. Diffuse morbilliform eruption after consumption of ginkgo biloba supplement. J. Am. Acad. Dermatol. 46 (2002) 145-146
79. Chung H., Harris A., Kristinsson J., Ciulla T., Kagemann C., and Ritch R. Ginkgo biloba extract increases ocular blood flow velocity. J. Ocul. Pharmacol. Ther. 15 (1999) 233-240
80. Ciganda C., and Laborde A. Herbal infusions used for induced abortion. J. Toxicol. Clin. Toxicol. 41 (2003) 235-239
81. Ciocon J., Ciocon D., and Galindo D. Dietary supplements in primary care. Botanicals can affect surgical outcomes and follow-up. Geriatrics 59 (2004) 20-24
82. Clouatre D. Kava kava: Examining new reports of toxicity. Toxicol. Lett. 150 (2004) 85-96
83. Cocks H., and Wilson D. Letter. Burns 24 (1998) 82
84. Conover E. Herbal agents and over-the-counter medications in pregnancy. Best Pract. Res. Clin. Endocrinol. Metab. 17 (2003) 237-251
85. Conover E., and Buehler B. Use of herbal agents by breastfeeding women may affect infants. Pediatr. Ann. 33 (2004)
86. Corazza M., Levratti A., and Virgili A. Allergic contact cheilitis due to carvone in toothpastes. Contact Dermatit. 46 (2002) 366-367
87. Cox N., and Hinkle R. Infant botulism. Am. Fam. Phys. 65 (2002) 1388-1392
88. Cox P., and Roche D. Directive 2004/24/EC of the European Parliament and of the Council. J. Eur. Union 136 (2004) 85-90
89. Crawford G., Sciacca J., and James W. Tea tree oil: Cutaneous effects of the extracted oil of Melaleuca alternifolia. Dermatitis 15 (2004) 59-66
90. Critchley J., Zhang Y., Suthisisang C., Chan T., and Tomlinson B. Alternative therapies and medical science: Designing clinical trials of alternative/complementary medicines-is evidence-based traditional Chinese medicine attainable?. J. Clin. Pharmacol. 40 (2000) 462-467
91. Cui J.-. Identification and quantification of ginsenosides in various commercial ginseng preparations. Eur. J. Pharmaceut. Sci. 3 (1995) 77-85
92. Cupp M. Herbal remedies: Adverse effects and drug interactions. Am. Fam. Phys. 59 (1999) 1239-1244
93. Cupp M. Patients' understanding of herbal product "suggested use: And "disclaimer" statements [Letter]. Ann. Pharmacother. 37 (2003) 1148
94. Czech E., Kneifel W., and Kopp B. Microbiological status of commercially available medicinal herbal drugs-a screening study. Planta Med. 67 (2001) 263-269
95. Dalvi S., Nayak V., Pohujani S., Desai N., Kshirsagar N., and Gupta K. Effect of gugulipid on bioavailability of diltiazem and propranolol. J. Assoc. Phys. India 42 (1994) 454-455
96. Damm D., Curran A., White D., and Drummond J. Leukoplakia of the maxillary vestibule-an association with Viadent?. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodont. 87 (1999) 61-66
97. Dandekar U., Chandra R., Dalvi S., Joshi M., Gokhale P., Sharma A., Shah P., and Kshirsagar N. Analysis of a clinically important interaction between phenytoin and Shankhapushpi, an Ayurvedic preparation. J. Ethnopharmacol. 35 (1992) 285-288
98. D'Arcy P. Adverse reactions and interactions with herbal medicines. Part 1. Adverse reactions. Adverse Drug Reaction Toxicol. Rev. 10 (1991) 189-208
99. D'Arcy P. Adverse reactions and interactions with herbal medicines. I. Adverse reactions. Adverse Drug Reaction Toxicol. Rev. 12 (1993) 147-162
100. Dasgupta A. Review of abnormal laboratory test results and toxic effects due to use of herbal medicines. Am. J. Clin. Pathol. 120 (2003) 127-137
101. Datta D., Khuroo M., Mattocks A., Aikat B., and Chhuttani P. Herbal medicines and veno-occlusive disease in India. Postgrad. Med. J. 54 (1978) 511-515
102. Davis J., and McCoy J.-A. "Commercial Goldenseal Cultivation", (2000), North Carolina State University 1-5
103. de Krom M., Boreas A., and Hardy E. Manganese poisoning due to use of Chien Pu Wan tablets [Dutch]. Nederlands Tijdschrift voor Geneeskunde 138 (1994) 2506
104. de la Torre M.F., Sanchez, Machin I., Garcia, Robaina J.C., Fernandez-Caldas E., Sanchez, and Trivino M. Clinical cross-reactivity between Artemisia vulgaris and Matricaria chamomilla (chamomile). J. Investig. Allergol. Clin. Immunol. 11 (2001) 118-122
105. De Smet P. "Legislatory Outlook on the Safety of Herbal Remedies" (1993), Springer-Verlag, Heidelberg
106. De Smet P. Herbal remedies. N. Engl. J. Med. 347 (2002) 2046-2056
107. De Smet P. Health risks of herbal remedies: An update. Clin. Pharmacol. Ther. 76 (2004) 1-17
108. De Smet P., and Brouwers J. Pharmacokinetic evaluation of herbal remedies. Basic introduction, applicability, current status and regulatory needs. Clin. Pharmacokinet. 32 (1997) 427-436
109. De Smet P., Stricker B., Wilderink F., and Wiersinga W. Hyperthyroidism during treatment with kelp tablets [Dutch]. Nederlands Tijdschrift Geneeskunde 134 (1990) 1058-1059
110. De Smet P.A.G.M. "Drugs Used in Non-Orthodox Medicine". 12th Ed. (1992), Elsevier, Amsterdam
111. Deahl M. Betel nut-induced extrapyramidal syndrome: An unusual drug interaction. Movement Disord. 4 (1989) 330-332
112. Desai H., Seabolt J., and Jann M. Smoking in patients receiving psychotropic medications: A pharmacokinetic perspective. CNS Drugs 15 (2001) 469-494
113. De Smet P.A.G.M., Keller K., Hansel R., and Chandler R. "Adverse Effects of Herbal Drugs" (1996), Springer-Verlag, New York
114. Dickens P., Tai Y., But P., Tomlinson B., Ng H., and Yan K. Fatal accidental aconitine poisoning following ingestion of Chinese herbal medicine: A report of two cases. Forens. Sci. Intl. 67 (1994) 55-58
115. Dong H., Chen S., Kini R., and Xu H. Effects of tannins from Geum japonicum on the catalytic activity of thrombin and factor Xa of blood coagulation cascade. J. Nat. Products 61 (1998) 1356-1360
116. Dourakis S., Papanikolaou I., Tzemanakis E., and Hadziyannis S. Acute hepatitis associated with herb (Teucrium capitatum L.) administration. Eur. J. Gastroenterol. Hepatol. 14 (2002) 693-695
117. Drake T., and Maibach H.I. Allergic contact dermatitis and stomatitis caused by a cinnamic aldehyde-flavored toothpaste. Arch. Dermatol. 112 (1976) 212-203.
118. Dresser G., Bailey D., and Carruthers S. Grapefruit juice-felodipine interaction in the elderly. Clin. Pharmacol. Ther. 68 (2000) 28-34
119. Dresser G., Bailey D., Leake B., Schwarz U., Dawson P., Freeman D., and Kim R. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin. Pharmacol. Ther. 71 (2002) 11-20
120. Drew A., and Myers S. Safety issues in herbal medicine, implication for the health professions. Med. J. Aust. 166 (1997) 538-541
121. Dutkiewicz J., Skorska C., Milanowski J., Mackiewicz B., Krysinska-Traczyk E., Dutkiewicz E., Matuszyk A., Sitkowska J., and Golec M. Response of herb processing workers to work-related airborne allergens. Ann. Agriculture Environ. Med. 8 (2001) 275-283
122. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., Van Rompay M., and RC K. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 280 (1998) 1569-1575
123. Elinav E., and Chajek-Shaul T. Licorice consumption causing severe hypokalemic paralysis. Mayo Clin. Proc. 78 (2003) 767-768
124. Elvin-Lewis M. Should we be concerned about herbal remedies. J. Ethnopharmacol. 75 (2001) 141-164
125. Elvin-Lewis M. Neem: From ethnodentistry to dental products: A review of its antiodontopathic potential. In: Behl H. (Ed). "Proceedings of World Neem Conference, University of British Columbia, Vancouver, Canada," (2002), Neem Foundation, Mumbai, India 176-186
126. Elvin-Lewis M. New therapeutic discoveries from ethnomedical and ethnobotanical data. Memorias del Simposio de la Flora y Fauna del Caribe. (2003) 1-19
127. Elvin-Lewis M. Optimizing the discovery of new therapeutics from ethnomedical and ethnobotanical sources in the Context of Emerging Policies and Laws Protecting Genetic Resources and Collective Traditional Knowledge. "Indigenous Knowledge and Bioprospecting" (2004), Maquarie University, Sydney, Australia
128. Elvin-Lewis M., Hamiolos D., el-Najdawi E., and Wedner H. Essential oil hypersensitivity in aphthous stomatitis patients. J. Dental Res. 64 (1985) 33
129. Elvin-Lewis M., Vitale M., and Kopjas T. The anti-cariogenic potential of commercial teas. J. Prev. Dentistry 6 (1980) 273-284
130. Enlow M. Spotlight ADR. Herbal hepatotoxicity. Pharmacol. Toxicol. 21 (1996) 162
131. Eriksson M., Ghani N.A., and Kristiansson B. Khat-chewing during pregnancy-Effect upon the off-spring and some characteristics of the chewers. East Afr. Med. J. 68 (1991) 106-111
132. Erlund I., Kosonen T., Alfthan G., Maenpaa J., Perttunen K., Kenraali J., Parantainen J., and Aro A. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur. J. Clin. Pharmacol. 56 (2000) 545-553
133. Ernst E. Harmless herbs? A review of the recent literature. Am. J. Med. 104 (1998) 170-178
134. Ernst E. Adverse effects of herbal drugs in dermatology. Br. J. Dermatol. 143 (2000) 923-929
135. Ernst M. Heavy metals in traditional Indian remedies. Eur. J. Pharmaceut. Sci. 57 (2002) 891-896
136. Ernst M. Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol. Sci. 23 (2002) 136-139
137. Ernst E. Adulteration of Chinese medicines with synthetic drugs: A systematic review. J. Intern. Med. Med. 252 (2002) 107-113
138. Ernst E. Cardiovascular adverse effects of herbal medicines: A systematic review of the recent literature. Can. J. Cardiol. 19 7 (2003) 818-827
139. ESCOP. "ESCOP Monographs on the Medicinal Uses of Plant Drugs" (1997), ESCOP, Exeter, United Kingdom
140. ESCOP. "ESCOP Monographs on the Medicinal Uses of Plant Drugs" (1999), ESCOP, Exeter, United Kingdom
141. Feng J., and Xie P. The importance and approaches of physicochemical properties analysis of active compounds of traditional Chinese herbs in development of new medicines. Zhongguo Zhong Yao Za Zhi 28 890 (2003) 798-800
142. Food and Drug Administration. FDA advises dietary supplement manufacturers to remove comfrey products from the market. US Food and Drug Administration (2001) Center for Food Safety and Applied Nutrition
143. Food and Drug Administration. (2004) FDA announces major initiatives for dietary supplements: Federal Drug Administration
144. Food and Drug Administration. Guidance for Industry: Botanical Drug Products: Food and Drug Administration (2004)
145. Food and Drug Administration. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule. Fed. Reg. 69 28 (2004) 6787-6854
146. Fox D., Hart M., Bergeson P., Jarrett P., Stillman A., and Huxtable R. Pyrrolizidine (Senecio) intoxication mimicking Reye syndrome. J. Pediatr. 93 (1978) 980-982
147. Francalanci S., Sertoli A., Giorgini S., Pigatto P., Santucci B., and Valsecchi R. Multicentre study of allergic contact cheilitis from toothpastes. Contact Dermatit. 43 (2000) 216-222
148. Franklin P. Review, critique, and guidelines for the use of herbs and homeopathy. J. Child Fam. Nurs. 2 (1999) 418-419
149. Galloway J., Farmer K., Weeks G., Marsh I., and Forrest A. Potentially hazardous compound in a herbal slimming remedy. Lancet 340 (1992) 179
150. Gandolfo G., Girelli G., Conti L., Perrone M., and Arista M. Hemolytic anemia and thrombocytopenia induced by cyanidanol. Acta Haematol. 88 (1992) 96-99
151. Garner L., and Klinger J. Some visual effects caused by the beverage kava. J. Ethnopharmacol. 13 (1985) 307-311
152. Gelenberg A., Shelton R., Crits-Christoph P., Keller M., Dunner D., Hirschfeld R., Thase M., Russell J., Lydiard R., Gallop R., Todd L., Hellerstein D., Goodnick P., Keitner G., Stahl S., Halbreich U., and Hopkins H. The effectiveness of St. John's Wort in major depressive disorder: A naturalistic phase 2 follow-up in which nonresponders were provided alternate medication. J. Clin. Psychiatry 65 (2004) 114-119
153. Ghani A.N., Eriksson M., Kristiansson B., and Qirbi A. The influence of khat-chewing on birth-weight in full-term infants. Social Sci. Med. 24 (1987) 625-627
154. Gilhooley M. Pharmaceutical drug regulation in China. Food Drug Cosmetic Law J. 44 (1989) 21-39
155. Glisson J., Crawford R., and Street S. Review, critique, and guidelines for the use of herbs and homeopathy. Nurse Pract. 24 53 (1999) 44-46, 60 passim, quiz 68-69
156. Goday B., Oleaga M.J., Yanguas B.I., Gonzalez G.M., and Soloeta A.R. Allergic contact dermatitis from krameria triandra extract. Contact Dermatit. 38 (1999) 120-121
157. Golec M., Skorska C., Mackiewicz B., and Dutkiewicz J. Immunologic reactivity to work-related airborne allergens in people occupationally exposed to dust from herbs. Ann. Agric. Environ. Med. 11 (2004) 121-127
158. Gonzalez-Seijo J., Ramos Y.M., and Lastra I. Manic episode and ginseng: Report of a possible case. J. Clin. Psychopharmacol. 15 (1995) 447-448
159. Gou Y., Ho A., Rowlands D., Chung Y., and Chan H. Effects of Bak Foong Pill on blood coagulation and platelet aggregation. Biol. Pharmaceut. Bull. 26 (2003) 241-246
160. Grover J., Yadav S., and Vats V. Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol. 81 (2002) 81-100
161. Guerra A. Nephrotoxicity of Peruvian herbal remedy containing. Ormosia cocinea (2005) . (personal communication)
162. Guzelcan Y., Scholte W., Assies J., and Becker H. Mania during the use of a combination preparation with St. John's wort (Hypericum perforatum). [in Dutch]. Neder. Tijdschrift Geneeskunde 145 (2001) 1243-1945
163. Haller C., Duan M., Benowitz N.L., and Jacob III P. Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements. J. Analyt. Toxicol. 28 (2004) 145-151
164. Hamouda C., Hedhili A., Ben Salah N., Zhioua M., and Amamou M. A review of acute poisoning from Atractylis gummifera L. Vet. Hum. Toxicol. 46 (2004) 144-146
165. Harkey M., Henderson G.L., Gershwin M.E., Stern J.S., and Hackman R.M. Variability in commercial ginseng products: An analysis of 25 preparations. Am. J. Clin. Nutr. 73 (2001) 1101-1106
166. Harris D., and Nowara G. The characteristics and causes of sheep losses in the Victorian Mallee. Aust. Vet. J. 72 (1995) 331-340
167. Harris I.S. Widespread ignorance of regulation and labeling of vitamins, minerals and food supplements. National Harris Interactive survey. (2003). http://www.harrisinteractive.com/news/allnewsbydale.asp
168. Hartigan-Go K. Developing a Pharmacovigilance system in the Philippines, a country of diverse culture and strong traditional medicine background. Toxicology (2002) 181-182, 103-107
169. Hasslberger J. European directive on medicinal herbs discriminates against China, India, other cultures (2004) newmediaexplorer.org/sept/2004/07/19/european_dorective_on_medicinal_herbs
170. Hausen B. Occupational contact allergy to feverfew Tanacetum parthenium (L.) Schultz-Bip. Asteraceae [German]. Dermatosen in Beruf und Umwelt. Occup. Environ. 29 (1981) 18-21
171. Hausen B. Toothpaste allergy. Deutsch Med. Wochenschr. 109 (1984) 300-302
172. Health Canada. Natural Health Products Directorate (NHPD): Progress on the 53 Recommendations of the Standing Committee on Health, (2004), Health Canada, Ottawa 1-17
173. Heptinstall S., Groenewegen W., Spangenberg P., and Loesche W. Extracts of feverfew may inhibit platelet behavior via neutralization of sulphydryl groups. J. Pharm. Pharmacol. 39 (1987) 459-465
174. Heron S., and Yarnell E. The safety of low-dose Larrea tridentata (DC) Coville (creosote bush or chaparral): A retrospective clinical study. J. Alt. Complemen. Med. 7 (2001) 175-185
175. Hohmann H., and Koffler K. Risk of adverse reactions from contaminants in Chinese herbal medicines minimized by using quality products and qualified practitioners. Int. J. Environ. Health Res. 12 (2002) 99-100 ; author reply 101
176. Holmes G., and Freeman S. Cheilitis caused by contact urticaria to mint flavored toothpaste. Aust. J. Dermatol. 42 (2001) 43-45
177. Homma M., Oka K., Yamada T., Niitsuma T., Ihto H., and Takahashi N. A strategy for discovering biologically active compounds with high probability in traditional Chinese herb remedies: An application of saiboku-to in bronchial asthma. Ann. Biochem. 202 (1992) 179-187
178. Hopkins M., Androff L., and Benninghoff A. Ginseng face cream and unexplained vaginal bleeding. Am. J. Obstet. Gynecol. 159 (1988) 1121-1122
179. Horowitz R., Feldhaus K., Dart R., Stermitz F., and Beck J. The clinical spectrum of Jin Bu Huan toxicity. Arch. Intern. Med. 156 (1996) 899-903
180. Hosseini S., Pishnamazi S., Sadrzadeh S.M., Farid F., Farid R., and Watson R.R. Pycnogenol in the management of asthma. J. Med. Food 4 4 (2001) 201-209
181. Huang S., Hall S., Watkins P., Love L., Serabjit-Singh C., Betz J., Hoffman F., Honig P., Coates P., Bull J., Chen S., Kearns G., and Murray M. Drug interactions with herbal products and grapefruit juice: A conference report. Cliln. Pharmacol. Ther. 75 (2004) 1-12
182. Huxtable R. The harmful potential of herbal and other plant products. Drug Safety 5 (1990) 126-136
183. Ishikawa K., Matsui K., Madarame T., Sato S., Oikawa K., and Uchida T. Hepatitis E probably contracted via a Chinese herbal medicine, demonstrated by nucleotide sequencing. J. Gastroenterol. 30 (1995) 534-538
184. Isnard Bagnis C., Deray G., Baumelou A., Le Quintrec M., and Vanherweghem J.L. Herbs and the kidney. Am. J. Kidney Dis. 44 (2004) 1-11
185. Ize-Ludlow D., Ragone S., Bruck I., Bernstein J., Duchowny M., and Pena B.M. Neurotoxicities in infants seen with the consumption of star anise tea. Pediatrics 114 (2004) 653-656
186. Izzo A., and Ernst E. Interactions between herbal medicines and prescribed drugs: A systematic review. Drugs 61 (2001) 2163-2175
187. Jackson C.-J.C., Dini J.P., Lavandier C., Faulkner H., Rupasinghe H.P.V., and Proctor J.T.A. Ginsenoside content of North American ginseng (Panax quinquefolius L. Araliaceae) in relation to plant development and growing locations. J. Ginseng Res. 27 (2003) 135-140
188. Japan Pharmaceutical Information Center. "Drugs in Japan, OTC Drugs (2000-2001)" (1998), Yakugyo Jiho Co. Ltd., Tokyo, Japan
189. Jefferson J. Diuretics are dangerous with lithium. BMJ 281 (1980) 1217
190. Jensen-Jarolim E., Reider N., Fritsch R., and Breiteneder H. Fatal outcome of anaphylaxis to chamomile-containing enema during labor: A case study. J. Allergy Cliln. Immunol. 102 (1998) 1041-1042
191. Jha V., and Chugh KS. Nephropathy associated with animal, plant, and chemical toxins in the tropics. Semin. Nephrol. 23 (2003) 49-65
192. Johanns E., van der Kolk L., van Gemert H., Sijben A., Peters P., and de Vries I. An epidemic of epileptic seizures after consumption of herbal tea. [in Dutch]. Neder. Tijdschrift Geneeskunde 146 (2002) 813-816
193. Jones T., and Lawson B. Profound neonatal congestive heart failure caused by maternal consumption of blue cohosh herbal medication>. J. Pediatr. 132 (1998) 550-552
194. Jovanovic M., Poljacki M., Duran V., Vujanovic L., Sente R., and Stojanovic S. Contact allergy to Compositae plants in patients with atopic dermatitis. Med. Pregled. 57 (2004) 209-218
195. Kairis M. Hepatotoxicity due to Atractylis gummifera. Arch. Hellenic Pathol. 10 (1996) 38-40
196. Kanda H., Sakurai M., and Arima K. Licorice of 'shakuyaku kanzou tou' induced pseudoaldosteronism. [in Japanese]. Hinyokida Kiyo 50 (2004) 215-217
197. Kane J., Kane S., and Jain S. Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 36 (1995) 146-147
198. Kang-Yum E., and Oransky S. Chinese patent medicine as a potential source of mercury poisoning. Vet. Human Toxicol. 34 (1992) 235-238
199. Kassler W., Blanc P., and Greenblatt R. The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch. Intern. Med. 151 (1991) 2281-2288
200. Kawasaki Y., Goda Y., and Yoshihira K. The mutagenic constituents of Rubia tinctorum. Chem. Pharmaceut. Bull. (Tokyo) 40 (1992) 1504-1509
201. Kemp D., and Franco K.N. Possible leukopenia associated with long-term use of Echinacea. J. Am. Board Fam. Pract. 15 (2002) 417-419
202. Kew J., Morris C., Aihie A., Fysh R., Jones S., and Brooks D. Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ 306 (1993) 506-507
203. Klepser T., Doucette W., Horton M., Buys L., Ernst M., Ford J., Hoehns J., Kautzman H., Logemann C., Swegle J., Ritho M., and Klepser M. Assessment of patients' perceptions and beliefs regarding herbal therapies. Pharmacotherapy 20 (2000) 83-87
204. Kneifel W., Czech E., and Kopp B. Microbial contamination of medicinal plants-a review. Planta Med. 68 (2002) 5-15
205. Knight T., and Hausen B. Melaleuca oil (tea tree oil) dermatitis. J. Am. Acad. Dermatol. 30 (1994) 423-427
206. Ko R. Causes, epidemiology, and clinical evaluation of suspected herbal poisoning. J. Toxicol. Clin. Toxicol. 37 (1999) 697-708
207. Ko R. A U.S. perspective on the adverse reactions from traditional Chinese medicines. J. Chinese Med. Assoc. 67 (2004) 109-116
208. Koh H., and Woo S. Chinese proprietary medicine in Singapore: Regulatory control of toxic heavy metals and undeclared drugs. Drug Safety 23 (2000) 351-362
209. Kumana C., Ng M., Lin H.J., Ko W., Wu P.C., and Todd D. Herbal tea induced hepatic veno-occlusive disease: Quantification of toxic alkaloid exposure in adults. Gut 26 (1985) 101-104
210. Kurvilla A. Herbal formulations as pharmacotherapeutic agents. Indian J. Exp. Biol. 40 (2002) 7-11
211. Lacoursiere R., and Swatek R. Adverse interaction between disulfiram and marijuana: A case report. Am. J. Psychiatry 140 (1983) 243-244
212. Lai R., Chiang A., Wu M., Wang J., Lai N., Lu J., Ger L., and Roggli V. Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan. Lancet 348 (1996) 83-85
213. Lam A., Elmer G., and Mohutsky M. Possible interaction between warfarin and Lycium barbarum L. Ann. Pharmacother. 35 (2001) 1199-1201
214. Lambert J., and Cormier A. Potential interaction between warfarin and boldo-fenugreek. Pharmacotherapy 21 (2001) 509-512
215. Larrey D. Liver involvement in the course of phytotherapy [in French]. Presse Med. 23 (1994) 691-693
216. Larrey D. Hepatotoxicity of herbal remedies. J. Hepatol. 26 (1997) 47-51
217. Lau A., Woo S., and Koh H.L. Analysis of saponins in raw and steamed Panax notoginseng using high-performance liquid chromatography with diode array detection. J. Chromatogr. A. 1011 (2003) 77-87
218. Lau B., Riesen S.K., Truong K.P., Lau E.W., Rohdewald P., and Barreta R.A. Pycnogenol as an adjunct in the management of childhood asthma. J. Asthma 41 (2004) 825-832
219. Lee A., and Werth V. Activation of autoimmunity following use of immunostimulatory herbal supplements. Arch. Dermatol. 140 (2004) 723-727
220. Lee K. Research and future trends in the pharmaceutical development of medicinal herbs from Chinese medicine. Public Health Nutr. 3 (2000) 515-522
221. Leung A. "Chinese Medicinals" (1990), Timber Press, Portland, Oregon
222. Levitt C., Godes J., Eberhardt M., Ing R., and Simpson J. Sources of lead poisoning. JAMA 252 (1984) 3127-3128
223. Lewis W. "American Ginseng: A Forest Crop" (1990), Missouri Department of Conservation, Jefferson City
224. Lewis W. Cat's claw taxonomy. Personal communication (2004)
225. Lewis W., Vaisberg A., Lamas G., Sarasara C., and Elvin-Lewis M. Advantage of ethnobotanically-based research for searching new pharmaceuticals. Ethnobotany 16 (2004) 10-15
226. Liang W.-L., Lin S.-W., Yen K.-Y., and Yang L.-L. Metal element analysis of commercial Chinese herbal medicines. Taiwan Kexue 51 (1998) 37-56
227. Liberti L.E., and Marderosian A.D. Evaluation of commercial ginseng products. J. Pharmaceut. Sci. 67 (1978) 1487-1489
228. Littleton J., Falcone D., and Davies H.M. Rediscovering plant-based drugs. Nat. Biotechnol. 21 (2003) 843-844
229. Liu X., Wei J., Tan F., Zhou S., Wurthwein G., and Rohdewald P. Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients. Life Sci. 74 (2004) 855-862
230. Luyckx V., Ballantine R., Claeys M., Cuyckens F., Van den Heuve I.H., Cimanga R., Vlietinck A., De Broe M., and Katz I. Herbal remedy-associated acute renal failure secondary to Cape aloes. Am. J. Kidney Dis. 39 (2002) E13
231. Lyford C., Vergara G., and Moeller D. Hepatic veno-occlusive disease originating in Ecuador. Gastroenterology 70 (1976) 105-108
232. Maechel H. Cirkan-induced chronic diarrhea [French]. Gastroenterol. Clin. Biol. 16 (1992) 373
233. Mai I.K.H., Budde K., Johne A., Brockmoller J., Neumayer H.H., and Roots I. Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin. Intl. J. Clin. Pharmacol. Ther. 38 (2000) 500-502
234. Makheja A., and Bailey J. The active principle in feverfew. Lancet 2 (1981) 1054
235. Makheja A., and Bailey J.M. A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium). Protagland. Leukotr. Med. 8 (1982) 653-660
236. Makino T., Wakushima H., Okamoto T., Okukubo Y., Deguchi Y., and Kano Y. Pharmacokinetic interactions between warfarin and kangen-karyu, a Chinese traditional herbal medicine, and their synergistic action. J. Ethnopharmacol. 82 (2002) 35-40
237. Makino T., Wakushima H., Okamoto T., Okukubo Y., Deguchi Y., and Kano Y. Pharmacokinetic and pharmacological interactions between ticlopidine hydrochloride and Kangen-Karyu-Chinese traditional herbal medicine. Phytother. Res. 17 (2003) 1021-1024
238. Mantani N., Kogure T., Sakai S., Goto H., Shibahara N., Kita T., Shimada Y., and Terasawa K. Incidence and clinical features of liver injury related to Kampo (Japanese herbal) medicine in 2,496 cases between 1979 and 1999: Problems of the lymphocyte transformation test as a diagnostic method. Phytomedicine 9 (2002) 280-287
239. Marcus D., and Grollman A. Botanical medicines-the need for new regulations. N. Engl. J. Med. 347 (2002) 2073-2076
240. Martins H., Martins M., Dias M., and Bernardo F. Evaluation of microbiological quality of medicinal plants used in natural infusions. Intl. J. Food Microbiol. 68 (2001) 149-153
241. Mascarenhas A., Allen C., and Moeschberger M. The association between Viadent use and oral leukoplakia-results of a matched case-control study. J. Public Health Dentistry 62 (2002) 158-162
242. Mashour N.H., and Frishman W.H. Herbal medicine for the treatment of cardiovascular disease: Clinical considerations. Arch. Intern. Med. 158 (1998) 2225-2234
243. Mathews J., Riley M., Fejo L., Munoz E., Milns N., Gardner I., Powers J., Ganygulpa E., and Gununuwawuy B. Effects of the heavy usage of kava on physical health: Summary of a pilot survey in an aboriginal community. Med. J. Aust. 148 (1988) 548-555
244. Matthews M.J. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 50 (1998) 1933-1934
245. Maurice P., and Cream J. The dangers of herbalism. BMJ 299 (1989) 1204
246. Mawrey D.B. "Herbal Tonic Therapies" (1993), Keats Publishing, Inc., New Canaan, CN
247. Mazzanti G., Battinelli L., Daniele C., Mastroianni C., Lichtner M., Coletta S., and Costantini S. New case of acute hepatitis following the consumption of Shou Wu Pian, a Chinese herbal product derived from Polygonum multiflorum. Ann. Intern. Med. 140 (2004) W30
248. McCoubrie M. Doctors as patients: Lisinopril and garlic [Letter]. Br. J. Gen. Practice 46 (1996) 107
249. McElvaine M., Harder E., Johnson L., Baer R., and Satzger R. Lead poisoning from the use of Indian folk medicines. J. Am. Med. Assoc. 264 (1991) 2212-2213
250. McGuffin M. Herbal medicine: Letter. N. Engl. J. Med. 348 (2002) 1498-1499
251. McGuffin M., and Young A. Premarket notifications of new dietary ingredients-a ten year review. Food Drug Law J. 59 (2004) 229-244
252. McRae C., Agarwal K., Mutimer D., and Bassendine M. Hepatitis associated with Chinese herbs. Eur. J. Gastroenterol. Hepatol. 14 (2002) 559-562
253. Mehta D.E. "British National Formulary" (2003) British Medical Association, Royal Pharmaceutical Society of Great Britain
254. Meisel C., Johne A., and Roots I. Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen. Atherosclerosis 167 (2003) 367
255. Melchart D., Linde K., Hager S., Kaesmayr J., Shaw D., Bauer R., and Weidenhammer W. Monitoring of liver enzymes in patients treated with traditional Chinese drugs. Complement. Ther. Med. 7 (1999) 208-216
256. Melchart D., Linde K., Weidenhammer W., Hager S., Shaw D., and Bauer R. Liver enzyme elevations in patients treated with traditional Chinese medicine. J. Am. Med. Assoc. 282 (1999) 28-29
257. In: McGuffin M., Kartesz J.T., and Leung A.Y. (Eds). "Herbs of Commerce". 2nd Ed. (2000), American Herbal Products Association, Silver Springs, MD
258. Miller K., Liebowitz R., and Newby L. Complementary and alternative medicine in cardiovascular disease: A review of biologically based approaches. Am. Heart J. 147 (2004) 401-411
259. Miller L. Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions. Arch. Intern. Med. 127 (1998) 61-69
260. Miller L., and Murray W.E. "Herbal Medicinals: A Clinician's Guide" (1998), Pharmaceutical Products Press, New Tirj
261. Mitka M. FDA issues warning on "all-natural" herbal product found to contain Viagra. JAMA 289 (2003) 2786
262. Mochitomi Y., Inoue A., Kawabata H., Ishida S., and Kanzaki T. Stevens-Johnson syndrome caused by a health drink (Eberu) containing ophiopogonis tuber. J. Dermatol. 25 (1998) 662-665
263. Monterrey-Rodriguez J. Interaction between warfarin and mango fruit. Ann. Pharmacother. 36 (2002) 940-941
264. Morris C.A., and Avorn J. Internet marketing of herbal products. JAMA 290 (2003) 1505-1509
265. Moulds R., and Malani J. Kava: Herbal panacea or liver poison?. Med. J. Aust. 178 (2003) 451-453
266. Mullins R., and Heddle R. Adverse reactions associated with Echinacea: The Australian experience. Ann. Allergy Asthma Immunol. 88 (2002) 42-51
267. Murphy J. Preoperative considerations with herbal medicines. Am. Organ. Reg. Nurses J. 69 (1999)
268. Nadir A., Agrawal S., King P., and Marshall J. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am. J. Gastroenterol. 7 (1996)
269. Nambiar S., Schwartz R.H., and Constantino A. Hypertension in mother and baby linked to ingestion of Chinese herbal medicine. West. J. Med. 171 (1999) 152
270. Nathan P. Can the cognitive enhancing effects of ginkgo biloba be explained by its pharmacology?. Med. Hypoth. 55 (2000) 491-493
271. Nortier J., Depierreux M., and Vanherweghem J. Herbal remedies and nephrotoxicity [in French]. Rev. Med. Bruxelles 20 (1999) 9-14
272. Nortier J., Martinez M., Schmeiser H., Arl T.V., Bieler C., Petein M., Depierreux M., De Pauw L., Abramowicz D., Vereerstraeten P., and Vanherweghem J. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N. Engl. J. Med. 342 (2000) 1686-1692
273. Ocasio N., Solomowitz B., and Sher M. Natural remedies recommended for the management of oral health. N Y Dental J. 65 (1999) 22-24
274. ODS. "Promoting Quality Science in Dietary Supplement Research, Education and Communication: A Strategic Plan for the Office of Dietary Supplements 2004-2009" (2004), Office of Dietary Supplements, NIH
275. Offman E., Freeman D., Dresser G., Munoz C., Bend J., and Bailey D. Red wine-cisapride interaction: Comparison with grapefruit juice. Clin. Pharmacol. Ther. 70 (2001) 17-23
276. O'Hara M., Kiefer D., Farrell K., and Kemper K. A review of 12 commonly used medicinal herbs. Arch. Fam. Med. 7 (1998) 523-536
277. Oliver M.R., Van Voorhis W.C., Boeckh M., Mattson D., and Bowden R.A. Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine. Clin. Infect. Dis. 22 (1996) 521-524
278. Opper F.H., Isaacs K.L., and Warshauer D.M. Esophageal obstruction with a dietary fiber product designed for weight reduction. Related Articles,. J. Clin. Gastroenterol. 12 (1990) 667-669
279. Pak E., Esrason K.T., and Wu V.H. Hepatotoxicity of herbal remedies: An emerging dilemma. Progress Transpl. 14 (2004) 91-96
280. Palmer B., Montgomery A., and Monteiro J. Gin Seng and mastalgia. BMJ 1 (1978) 1284
281. Park G., Mann S., and Ngu M. Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum. J. Gastroenterol. Hepatol. 16 (2001) 115-117
282. Paulsen E. Contact sensitization from Compositae-containing herbal remedies and cosmetics. Contact Dermatit. 47 (2002) 189-198
283. Paulsen E., Andersen K., Carlsen L., and Egsgaard H. Carvone: An overlooked contact allergen cross-reacting with sesquiterpene lactones?. Contact Dermatit. 29 (1993) 138-143
284. Peoples Republic of China. "Pharmacopoeia of the People's Republic of China" (2000), GuangDong Science and Technology Press, GuangDong, China
285. Perharic L., Shaw D., and Murray V. Toxic effects of herbal medicines and food supplements. Lancet 342 (1993) 180-181
286. Perharic L., Shaw D., Leon C., De Smet P., and Murray V. Possible association of liver damage with the use of Chinese herbal medicine for skin disease. Vet. Human Toxicol. 37 (1995) 562-566
287. Petty H., Fernando M., Kindzelskii A.L., Zarewych B.N., Ksebati M.B., Hryhorczuk L.M., and Mobashery S. Identification of colchicine in placental blood from patients using herbal medicines. Chem. Res. Toxicol. 19 (2001) 1254-1258
288. Physicians Desk Reference. "PDR for Herbal Medicines" (1998) Medical Economics Company
289. Picciotto A., Campo N., Brizzolara R., Giusto R., Guido G., Sinelli N., Lapertosa G., and Celle G. Chronic hepatitis induced by Jin Bu Huan. J. Hepatol. 28 (1998) 165-167
290. Pinn G., and Pallett L. Herbal medicine in pregnancy. Complement. Ther. Nurs. Midwifery 8 (2002) 77-80
291. Pittler M., and Ernst E. Systematic review: Hepatotoxic events associated with herbal medicinal products. Aliment. Pharmacol. Ther. 18 (2003) 451-471
292. Pradeepkumar V., Tan K., and Ivy N. Is "herbal health tonic" safe in pregnancy; fetal alcohol syndrome revisited. Aust. N Z J. Obstet. Gynaecol. 36 (1996) 420-423
293. Pye K., Kelsey S., House I., and Newland A. Severe dyserythropoiesis and autoimmune thrombocytopenia associated with ingestion of kelp supplements. Lancet 339 (1992) 1540
294. Pyevich D., and Bogenschutz M. Herbal diuretics and lithium toxicity. Am. J. Psychiatry 158 (2001) 1329
295. Raaska K., Raitasuo V., Laitila J., and Neuvonen P. Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalized patients. Basic Clin. Pharmacol. Toxicol. 94 (2004) 13-18
296. Rasenack R., Muller C., Kleinschmidt M., Rasenack J., and Wiedenfeld H. Veno-occlusive disease in a fetus caused by pyrrolizidine alkaloids of food origin. Fetal Diagn. Ther. 18 (2003) 223-225
297. Raskin I., Ribnicky D., Komarnytsky S., Ilic N., Poulev A., Borisjuk N., Brinker A., Moreno D., Ripoll C., Yakoby N., O'Neal J., Cornwell T., Pastor I., and Fridlender B. Plants and human health in the twenty-first century. Trends Biotechnol. 20 (2002) 522-531
298. Ravinder R., Asif A., and Shivkumar I. Herbal medicines: Need for stricter regulations. Express. Pharma. Pulse. (2003). May 22. http://www.express pharmapulse.com
299. Reider M.J. Mechanisms of unpredictable adverse drug reactions. Drug Safety 11 (1994) 196-212
300. Reider N., Sepp N., Fritsch P., Weinlich G., and Jensen-Jarolim E. Anaphylaxis to chamomile: Clinical features and allergen cross-reactivity. Clin. Exp. Allergy 30 (2000) 1436-1443
301. Rizzo I., Vedoya G., Maurutto S., Haidukowski M., and Varsavsky E. Assessment of toxigenic fungi on Argentinean medicinal herbs. Microbiol. Res. 159 (2004) 113-120
302. Roeder E. Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie 55 (2000) 711-726
303. Rosenblatt M., and Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N. Engl. J. Med. 336 (1997) 1108
304. Roulet M., Laurini R., Rivier L., and Calame A. Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea. J. Pediatr. 112 (1988) 433-436
305. Rudzki E., Rapiejko P., and Rebandel P. Occupational contact dermatitis, with asthma and rhinitis, from chamomile in a cosmetician also with contact urticaria from both chamomile and lime flowers. Contact Dermatit. 49 (2003) 162
306. Ruze P. Kava-induced dermopathy: A niacin deficiency?. Lancet 335 (1990) 1442-1445
307. Rycroft R. Recurrent facial dermatitis from chamomile tea. Contact Dermatit. 48 (2003) 229
308. Sadjadi J. Cutaneous anthrax associated with the Kombucha "mushroom" in Iran. JAMA 280 (1998) 1567-1568
309. Saito H. Regulation of herbal medicines in Japan. Pharmacol. Res. 41 (2000) 515-519
310. Saldanha L., Betz J., and Coates P. Development of the analytical methods and reference materials program for dietary supplements at the National Institutes of Health. J AOAC Intl. 87 (2004) 162-165
311. Samuels N. Herbal remedies and anticoagulant therapy. Thromb. Haemost. 93 (2005) 3-7
312. Sanders D., Kennedy N., and McKendrick M.W. Monitoring the safety of herbal remedies. Herbal remedies have a heterogeneous nature. BMJ 311 (1995) 1569
313. Sandler B., and Aronson P. Yohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome. Urology 41 (1993) 343-345
314. Saxe T. Toxicity of medicinal herbal preparations. Am. Fam. Phys. 35 (1987) 135-142
315. Scardamaglia L., Nixon R., and Fewings J. Compound tincture of benzoin: A common contact allergen?. Aust. J. Dermatol. 44 (2003) 180-184
316. Schaller M., and Korting H. Allergic airborne contact dermatitis from essential oils used in aromatherapy. Clin. Exp. Dermatol. 20 (1995) 143-145
317. Schaumburg H.H., and Berger A. Alopecia and sensory polyneuropathy from thallium in a Chinese herbal medication. JAMA 268 (1992) 3430-3431
318. Schilcher H. Contamination of natural products with pesticides and heavy metals. In: Breimer D., and Speiser P. (Eds). "Topics in Pharmaceutical Sciences" (1983), Elsevier Science, Amsterdam
319. Schonlau F., and Rohdewald P. Pycnogenol for diabetic retinopathy. A review. Intl. J. Ophthalmol. 24 (2001) 161-171
320. Schulman S. Care of patients receiving long-term anticoagulant therapy. N. Engl. J. Med. 349 (2003) 675-683
321. Scurr J., and Gulati O.P. Zinopin-the rationale for its use as a food supplement in Traveler's thrombosis and motion sickness. Phytother. Res. 18 (2004) 687-695
322. Seedat Y., and Hitchcock P. Acute renal failure from Callilepsis laureola. South Afr. Med. J. 45 (1971) 832-833
323. Seidner D., Roberts I.M., and Smith M.S. Esophageal obstruction after ingestion of a fiber-containing diet pill. Gastroenterology 99 (1990) 1820-1822
324. Selvaag E., Holm J., and Thune P. Contact allergy to essential oils. Tidsskrift for den Norske laergeforening 115 (1995) 3369-3370
325. Selvaag E., Holm J., and Thune P. Allergic contact dermatitis in an aroma therapist with multiple sensitizations to essential oils. Contact Dermatit. 33 (1995) 354-355
326. Shang M., Xu G., Xu L., and Li P. Herbalogical study of Chinese drug guijiu and xiaoyelian. [in Chinese]. Zhongguo Zhong Yao Za Zhi 19 (1994) 451-453, 510
327. Shaw D., Leion C., Kolev S., and Murray V. Traditional remedies and food supplements, a 5-year toxicological study (1991-1995). Drug Safety 17 (1997) 342-356
328. Sheerin N., Monk P., Aslam M., and Thurston H. Simultaneous exposure to lead, arsenic and mercury from Indian ethnic remedies. Br. J. Clin. Practice 48 (1994) 332-333
329. Sheikh N., Philen R., and Love L. Chaparral-associated hepatotoxicity. Arch. Intl. Med. 157 (1997) 913-919
330. Shekelle P., Hardy M., Morton S., Maglione M., Mojica W., Suttorp M., Rhodes S., Jungvig L., and Gagne J. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: A meta-analysis. JAMA 289 (2003) 1537-1545
331. Shekelle P., Hardy M., Morton S., Maglione M., Suttorp M., Roth E., Jungvig L., Mojica W., Gagne J., Rhodes S., and McKinnon E. Ephedra and ephedrine for weight loss and athletic performance enhancement: Clinical efficacy and side effects. Evidence Rep. Technol. Assessment (Summary) 76 (2003) 111-114
332. Shilo S., and Hirsch J. Iodine-induced hyperthyroidism in a patient with a normal thyroid gland. Postgrad. Med. 62 (1986) 661-662
333. Siegel R. Ginseng abuse syndrome: Problems with the panacea. JAMA 241 (1979) 1614-1615
334. Siegers C. Anthranoid laxatives and colorectal cancer. Trends Pharmacol. Sci. 13 (1992) 229-231
335. Simpson E., Law S., and Storrs F. Prevalence of botanical extract allergy in patients with contact dermatitis. Dermatitis 15 (2004) 67-72
336. Singh R., Niaz M., and Ghosh S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc. Drugs Ther. 8 (1994) 659-664
337. Skogh M. Extracts of Ginkgo biloba and bleeding or haemorrhage. Lancet 352 (1998) 1145-1146
338. Soller R. Regulation in the herb market: The myth of the "unregulated" industry. Herbalgram 49 (2000) 64-67
339. Soon S., and Crawford R. Recurrent erythema nodosum associated with Echinacea herbal therapy. J. Am. Acad. Dermatol. 44 (2001) 298-299
340. Spang R. Toxicity of tea containing pyrrolizidine alkaloids. J. Pediatr. 115 (1989) 1025
341. Sparber A., Ford D., and Kovochak P.A. National Institutes of Health's Clinical Center sets new policy on use of and other alternative supplements by patients enrolled in clinical trials. Cancer Invest. 22 (2004) 132-137
342. Sperber S., Shah L., Gilbert R., Ritchey T., and Monto A. Echinacea purpurea for prevention of experimental rhinovirus colds. Clin. Infect. Dis. 38 (2004) 1367-1371
343. Sperl W., Stuppner H., Gassner I., Judmaier W., Dietze O., and Vogel W. Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea. Eur. J. Pediatr. 154 (1995) 112-116
344. Srivastava K. Antiplatelet principles from a food spice clove (Syzygium aromaticum L). [appears erratum in Prostagland. Leukotr. Essential Fatty Acids 48, 363-372. Prostagland. Leukotr. Essential Fatty Acids 49 (1993) 885
345. Stedman C. Herbal hepatotoxicity. Semin. Liver Dis. 22 (2002) 195-206
346. Stein G., and Berg P. Characterisation of immunological reactivity of patients with adverse effects during therapy with an aqueous mistletoe extract. Eur. J. Med. Res. 4 (1999) 169-177
347. Steinberg D., and Beal M.W. Homeopathy and women's health care. J. Obstet. Gynecol. Neonatal Nurs. 32 (2003) 207-214
348. Stevinson C., Huntley A., and Ernst E. A systematic review of the safety of kava extract in the treatment of anxiety. Drug Safety 25 (2002) 251-261
349. Stickel F., Egerer G., and Seitz H. Hepatotoxicity of botanicals. Public Health Nutr. 3 (2000) 113-124
350. Stillman A., Huxtable R., Consroe P., Kohnen P., and Smith S. Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona. Gastroenterology 73 (1977) 349-352
351. Stockley I. "Stockley's Drug Interactions" (2002), The Pharmaceutical Press, London
352. Stoll A., Cole J., and Lukas S. A case of mania as a result of fluoxetine-marijuana interaction. J. Clin. Psychiatry 52 (1991) 280-281
353. Strahl S., Ehret V., Dahm H., and Maier K. Necrotizing hepatitis after taking herbal remedies [in German]. Deutsch Med. Wochensch. 123 (1998) 1410-1414
354. Subiza J., Subiza J., Alonso M., Hinojosa M., Garcia R., Jerez M., and Subiza E. Allergic conjunctivitis to chamomile tea. Ann. Allergy 65 (1990) 127-132
355. Subiza J., Subiza J.L., Hinojosa M., Garcia R., Jerez M., Valdivieso R., and Subiza E. Anaphylactic reaction after the ingestion of chamomile tea: A study of cross-reactivity with other composite pollens. J. Allergy Clin. Immunol. 84 (1989) 353-358
356. Sun L., An R., and Zhuang W. Renal toxicity of Aristolochia and its prevention [in Chinese]. Zhong Yao Cai 25 (2002) 369-371
357. Szapary P., Wolfe M., Bloedon L., Cucchiara A., Der Marderosian A., Cirigliano M., and Rader D. Guggulipid for the treatment of hypercholesterolemia: A randomized controlled trial. JAMA 290 (2003) 762-765
358. Tai Y., But P., Young K., and Lau C. Cardiotoxicity after accidental herb-induced aconite poisoning. Lancet 340 (1992) 1254-1256
359. Tait P., Vora A., James S., Fitzgerald D., and Pester B. Severe congenital lead poisoning in a preterm infant due to a herbal remedy. Med. J. Aust. 177 (2002) 193-195
360. Tanaka A., Nishida R., Maeda K., Sugawara A., and Kuwahara T. Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: Could different components of aristolochic acids cause a different type of Chinese herb nephropathy?. Clin. Nephrol. 53 (2000) 301-306
361. Tanzi M., and Gabay M. Association between honey consumption and infant botulism. Pharmacotherapy 22 (2002) 1479-1483
362. Tatlow W. The future of drugs from plants. Drug Disc. Today 15 (2003) 735-737
363. Teelucksingh S., Mackie A.D., Burt D., McIntyre M.A., Brett L., and Edwards C.R. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet 335 (1990) 1060-1063
364. Teng C., Ko F., Wang J., Lin C., Wu T., Chen C., and Huang T.F. Antihaemostatic and antithrombotic effect of some antiplatelet agents isolated from Chinese herbs. J. Pharm. Pharmacol. 43 (1991) 667-669
365. Thatte U.M., Rege N.N., Phatak S.D., and Dahanukar S.A. The flip side of Ayurveda. J. Postgrad. Med. 39 (1993) 179-182, 182a-182b
366. Thien F. Chamomile tea enema anaphylaxis. Med. J. Aust. 175 (2001) 54
367. Thurairaja R., Barrass B., and Persad R. Internet websites selling herbal treatments for erectile dysfunction. Intl. J. Impotency Res (2004)
368. Thyne G., Young D., and Ferguson M. Contact stomatitis caused by toothpaste. New Zeal. Dental J. 85 (1989) 124-126
369. Tomassoni A., and Simone K. Herbal medicines for children: An illusion of safety?. Curr. Opin. Pediatr. 13 (2001) 162-169
370. Tomlinson B., Chan T., Chan J., Critchley J., and But P. Toxicity of complementary therapies: An eastern perspective. J. Clin. Pharmacol. 40 (2000) 451-456
371. Tsiodras S., Shin R., Christian M., Shaw L., and Sass D. Anticholinergic toxicity associated with lupine seeds as a home remedy for diabetes mellitus. Ann. Emerg. Med. 33 (1999) 715-717
372. Tsumara A. "Kampo, How the Japanese Updated Traditional Herbal Medicine" (1991), Japan Publications, Inc., Tokyo and New York
373. Tyler V. "Herbs of Choice, The Therapeutic Use of Phytomedicines" (1994), Pharmaceutical Product Press, NY
374. Ueng T.-H., Kang J.-J., Wang H.-W., and Lin P.-C. An overview of the toxicology of commonly used traditional Chinese medicine. Yaowu Shipin Fenxi 5 (1997) 241-263
375. Upton R. "Hawthorn Leaf with Flowers (Crataegus spp.)" (1999), American Herbal Pharmacopoeia, Soquel, CA
376. Uzogara S. The impact of genetic modification of human foods in the 21st century: A review. Biotechnol. Adv. 18 (2000) 176-206
377. Vaddadi K. The use of gamma-linolenic acid and linoleic acid to differentiate between temporal lobe epilepsy and schizophrenia. Prostagland. Med. 6 (1981) 375-379
378. Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet 352 9161 (1998) 36
379. van Weeren P., Morales J., Rodriguez L., Cedeno H., Villalobos J., and Poveda L. Mortality supposedly due to intoxication by pyrrolizidine alkaloids from Heliotropium indicum in a horse population in Costa Rica: A case report. Vet. Q. 21 (1999) 59-62
380. Vilar J., Garcia M., and Cabrera P. Veno-occlusive liver disease induced by Senecio vulgaris toxicity [in Spanish] Gastroenterology and Hepatology 23 (2000) 285-286
381. Vogler B., and Ernst E. Aloe vera: A systematic review of its clinical effectiveness. Br. J. Gen. Practice 49 (1999) 823-828
382. Vuckovic N., and Nichter M. Changing patterns of pharmaceutical practice in the United States. Social Sci. Med. 44 (1997) 1285-1302
383. Walker J. Evaluation of the ability of seven herbal resources to answer questions about herbal products asked in drug information centers. Pharmacotherapy 22 (2002) 1611-1615
384. Waller D. "Report on Kava and Liver Damage" (2002), American Herbal Products Association, Silver Spring, MD
385. Wang J., Hsu M., and Teng C. Antiplatelet effect of capsaicin. Thromb. Res. 36 (1984) 497-507
386. Wasantapruek S., Poolsuppasit S., and Pibolnukarintr O. Enhanced fibrinolytic activity after capsicum ingestion. N. Engl. J. Med. 290 (1974) 1259-1260
387. Wauters C. Manganese poisoning caused by administration of Chien Pu Wan tablets [in Dutch]. Nederlands Tijdschrift voor Geneeskunde 139 (1995) 97
388. White L., Gardner S., Gurley B., Marx M., Wang P., and Estes M. Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults. J. Clin. Pharmacol. 37 (1997) 116-122
389. WHO/IUCN/WWF. "WHO/IUCN/WWF Guidelines on the Conservation of Medicinal Plants", (1993), Gland, Switzerland 1-51
390. Wilkie A., and Cordess C. Ginseng-a root just like a carrot?. J. R. Soc. Med. 87 (1994) 594-595
391. Williamson E. "Potter's Herbal Cyclopaedia" (2003), CW Daniel and Co., Saffron Walden, UK
392. Wilson C., Dettenkofer M., Jonas D., and Daschner F. Pathogen growth in herbal teas used in clinical settings: A possible source of nosocomial infection?. Am. J. Infect. Control 32 (2004) 117-119
393. Winship K. Toxicity of comfrey. Adv. Drug Reaction Toxicol. Rev. 10 (1991) 47-59
394. Wojcikowski K., Johnson D., and Gobe G. Medicinal herbal extracts-renal friend or foe? Part one: The toxicities of medicinal herbs. Nephrology (Carlton) 9 (2004) 318
395. Wong M., Tan P., and Wee Y. Heavy metals in some Chinese herbal plants. Biol. Trace Element Res. 36 (1993) 135-142
396. Woolf G., Perovic L., and Rojter S. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann. Intern. Med. 121 (1994) 729-735
397. Wooltorton E. Hua Fo tablets tainted with sildenafil-like compound. CMAJ Can. Med. Assoc. J. 166 (2002) 1568
398. World Health Organization. "Medicinal Plants in China" (1989), WHO Regional Office for the Western Pacific, Manila, Philippines
399. World Health Organization. "Medicinal Plants in Viet Nam" (1990), WHO Regional Office for the Western Pacific, Manila, Philippines
400. World Health Organization. "Regulatory Situation of Herbal Medicines" (1998), WHO, Geneva
401. World Health Organization. "Medicinal Plants in the Republic of Korea" (1998), WHO Regional Office for the Western Pacific, Manila, Philippines
402. World Health Organization. "Medicinal Plants in the South Pacific" (1998), Regional Office for the Western Pacific, Manila, Philippines
403. World Health Organization. "WHO Monographs on Selected Medicinal Plants" 4 volumes (1999), World Health Organization, Geneva
404. World Health Oganization. "General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine", (2000), World Health Organization, Geneva, Switzerland 1-74
405. World Health Organization. "WHO Guidelines on Good Agriculture and Collection Practices (GACP) for Medicinal Plants", (2003), World Health Organization, Geneva, Switzerland 1-72
406. World Health Organization. "Medicinal Plants-Guidelines to Promote Patient Safety and Plant Conservation for a US$ 60 Billion Industry", (2004), World Health Organization, Geneva, Switzerland 1-2
407. Wu L. Occurrence and physiological activities of trace elements in traditional Chinese drugs. Zhonghua Yaoxue Zazhi 44 (1992) 269-280
408. Wu T., Yang K., Wang C., Lai J., Ko K., Chang P., and Liou S. Lead poisoning caused by contaminated Cordyceps, a Chinese herbal medicine: Two case reports. Sci. Total Environ. 182 (1996) 193-195
409. Wuttke W., Jarry H., Christoffel V., Spengler B., and Seidlova-Wuttke D. Chaste tree (Vitex agnus-castus)-pharmacology and clinical indications. Phytomedicine 10 (2003) 348-357
410. Wyllie M. The genesis of a phyto-pharmaceutical industry (Mark II). BJU Int. 91 (2003) 721-722
411. Yeh G., Eisenberg D., Kaptchuk T., and Phillips R. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabet. Care 26 (2003) 1277-1294
412. Yeung C., Lee F., and Wong H. Effects of a popular Chinese herb on neonatal bilirubin protein bindin. Biol. Neonate 58 (1990) 98-103
413. Yu E., and Yeung C. Lead encephalopathy due to herbal medicine. Chin. Med. J. 199 (1987) 915
414. Yuan C., Wei G., Dey L., Karrison T., Nahlik L., Maleckar S., Kasza K., Ang-Lee M., and Moss J. Brief communication: American ginseng reduces warfarin's effect in healthy patients: A randomized, controlled trial. Ann. Intern. Med. 141 (2004) 23-27
415. Yue Q., and Jansson K. Herbal drug curbicin and anticoagulant effect with and without warfarin: Possibly related to the vitamin E component. J. Am. Geriatr. Soc. 49 (2001) 838
416. 2+ influx of platelets. Zhonghua Xue Ye Xue Za Zhi 25 (2004) 544-547
417. Zhao X., Chan M., and Ogle C. The identification of pyrrolizidine alkaloid-containing plants-a study on 20 herbs of the Compositae family. Am. J. Chin. Med. 17 (1989) 71-78
418. Zhou S., Koh H., Gao Y., Gong Z., and Lee E. Herbal bioactivation: The good, the bad and the ugly. Life Sci. 74 (2004) 935-968